EMA workflow at risk if Amsterdam building is delayed, say MEPs
In delegation to Amsterdam on Thursday, MEPs warned that delays on the delivery of the new Vivaldi building would have consequences on the agency’s business continuity.
A delegation of six MEPs from the Public Health committee carried a fact-finding mission to Amsterdam on Thursday 22 February, to which the EMA is to be relocated after Brexit.
The delegation, led by the rapporteur on the relocation, Giovanni La Via (EPP, IT) visited the temporary location and the future headquarters for the EMA, and discussed the relocation with the Agency’s executive Director Guido Rasi and Dutch Health ministry representatives.
“We thank the Dutch government for welcoming us and for the information given today. The temporary building, in fact, does not seem to need much work to be ready” said delegation Chairman Giovanni La Via (EPP, IT).
“We are more concerned about the risk of delay in the construction of the new Vivaldi building. EMA staff told us today that a delay would cause a deterioration of the Agency’s activity, which is precisely what we want to avoid” he added.
“We also have major doubts on the procedure followed by the Council: Parliament cannot be by-passed. Before we vote, Council and the Commission should give us assurances that any future decision regarding the seat of agencies will be taken under co-decision”.
“We will take all the information provided today into consideration, as well as the one requested yesterday by the President of the European Parliament in a letter to Jean-Claude Juncker, in the preparation of our vote” he said.
The Public Health committee is to vote on Giovanni La Via’s report on the 12th of March, and the full House later the same week.